Follow
John Mercer
John Mercer
Verified email at glasgow.ac.uk
Title
Cited by
Cited by
Year
Monocyte/macrophage suppression in CD11b diphtheria toxin receptor transgenic mice differentially affects atherogenesis and established plaques
V Stoneman, D Braganza, N Figg, J Mercer, R Lang, M Goddard, ...
Circulation research 100 (6), 884-893, 2007
3402007
Mitochondrial DNA damage can promote atherosclerosis independently of reactive oxygen species through effects on smooth muscle cells and monocytes and correlates with higher …
E Yu, PA Calvert, JR Mercer, J Harrison, L Baker, NL Figg, S Kumar, ...
Circulation 128 (7), 702-712, 2013
2852013
Vascular smooth muscle cell sirtuin 1 protects against DNA damage and inhibits atherosclerosis
I Gorenne, S Kumar, K Gray, N Figg, H Yu, J Mercer, M Bennett
Circulation 127 (3), 386-396, 2013
2832013
DNA damage links mitochondrial dysfunction to atherosclerosis and the metabolic syndrome
JR Mercer, KK Cheng, N Figg, I Gorenne, M Mahmoudi, J Griffin, ...
Circulation research 107 (8), 1021-1031, 2010
2752010
The mitochondria-targeted antioxidant MitoQ decreases features of the metabolic syndrome in ATM+/–/ApoE–/–mice
JR Mercer, E Yu, N Figg, KK Cheng, TA Prime, JL Griffin, M Masoodi, ...
Free Radical Biology and Medicine 52 (5), 841-849, 2012
2062012
Endogenous p53 protects vascular smooth muscle cells from apoptosis and reduces atherosclerosis in ApoE knockout mice
J Mercer, N Figg, V Stoneman, D Braganza, MR Bennett
Circulation research 96 (6), 667-674, 2005
2042005
Mitochondria in vascular disease
E Yu, J Mercer, M Bennett
Cardiovascular research 95 (2), 173-182, 2012
1772012
DNA damage and repair in atherosclerosis
M Mahmoudi, J Mercer, M Bennett
Cardiovascular research 71 (2), 259-268, 2006
1762006
Statins use a novel Nijmegen breakage syndrome-1–dependent pathway to accelerate DNA repair in vascular smooth muscle cells
M Mahmoudi, I Gorenne, J Mercer, N Figg, T Littlewood, M Bennett
Circulation research 103 (7), 717-725, 2008
1542008
DNA damage, p53, apoptosis and vascular disease
J Mercer, M Mahmoudi, M Bennett
Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis 621 (1 …, 2007
1372007
Effects of DNA damage in smooth muscle cells in atherosclerosis
K Gray, S Kumar, N Figg, J Harrison, L Baker, J Mercer, T Littlewood, ...
Circulation research 116 (5), 816-826, 2015
1082015
The role of p53 in atherosclerosis
J Mercer, M Bennett
Cell cycle 5 (17), 1907-1909, 2006
1002006
The future of cardiovascular stents: bioresorbable and integrated biosensor technology
D Hoare, A Bussooa, S Neale, N Mirzai, J Mercer
Advanced Science 6 (20), 1900856, 2019
802019
Battery‐free and wireless technologies for cardiovascular implantable medical devices
J Zhang, R Das, J Zhao, N Mirzai, J Mercer, H Heidari
Advanced Materials Technologies 7 (6), 2101086, 2022
592022
Impaired mitochondrial respiration in human carotid plaque atherosclerosis: A potential role for Pink1 in vascular smooth muscle cell energetics
CK Docherty, A Carswell, E Friel, JR Mercer
Atherosclerosis 268, 1-11, 2018
592018
Oxidative stress regulates IGF1R expression in vascular smooth-muscle cells via p53 and HDAC recruitment
MM Kavurma, N Figg, MR Bennett, J Mercer, LM Khachigian, ...
Biochemical Journal 407 (1), 79-87, 2007
552007
Extracellular vesicle signalling in atherosclerosis
E Charla, J Mercer, P Maffia, SA Nicklin
Cellular signalling 75, 109751, 2020
482020
Future of smart cardiovascular implants
A Bussooa, S Neale, JR Mercer
Sensors 18 (7), 2008, 2018
472018
How does juxtaluminal calcium affect critical mechanical conditions in carotid atherosclerotic plaque? An exploratory study
Z Teng, J He, U Sadat, JR Mercer, X Wang, NS Bahaei, OM Thomas, ...
IEEE Transactions on Biomedical Engineering 61 (1), 35-40, 2013
392013
Mitochondrial bioenergetics and therapeutic intervention in cardiovascular disease
JR Mercer
Pharmacology & therapeutics 141 (1), 13-20, 2014
322014
The system can't perform the operation now. Try again later.
Articles 1–20